NT_1170x120_1-11-18

Scott Melville

Video Forum: Scott Melville, CHPA

Video Forum: Scott Melville, CHPA

The latest installment in our Video Forum features Scott Melville, president and chief executive officer of the Consumer Healthcare Products Association. In addition to the rebranding of CHPA, Melville talks about what recently enacted O-T-C monograph reform means for the category, and the increasingly important part that nonprescription products are playing in health care.

CHPA names P&G’s Paul Gama as board chair

CHPA names P&G’s Paul Gama as board chair

WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced on Tuesday the appointment of Paul Gama as the new chair of the CHPA board of directors. Gama was elected on April 13, 2020, along with other new board members, at CHPA’s annual membership meeting conducted, for the first time ever, in a virtual forum online.

CHPA issues statement regarding O-T-C measures in COVID-19 legislation

CHPA issues statement regarding O-T-C measures in COVID-19 legislation

WASHINGTON— Consumer Healthcare Products Association (CHPA) president and CEO, Scott Melville, issued the following statement upon final passage of the CARES Act, which among its many sections includes provisions to update and modernize the regulatory system overseeing most over-the-counter (O-T-C) medicines and to restore O-T-C eligibility under tax-preferred HSA and FSA accounts. “During this unprecedented

CHPA names Dr. John Troup VP for scientific affairs and dietary supplements

CHPA names Dr. John Troup VP for scientific affairs and dietary supplements

WASHINGTON — The Consumer Healthcare Products Association (CHPA) announced the appointment of Dr. John Troup as vice president for scientific affairs and dietary supplements, a brand-new position within CHPA. Dr. Troup has wide-ranging experience in the health, nutrition and dietary supplements sectors, including extensive work in clinical and product development, as well as regulatory affairs.

Pharmacy Outlook: Scott Melville, CHPA

Pharmacy Outlook: Scott Melville, CHPA

Welcome to 2020, where, more than ever, patients and caregivers are taking control of their health care decisions and an increasing array of consumer health care products is helping them get well, stay healthy, treat minor ailments and even manage some chronic conditions. The marketplace is evolving before our eyes, including the manufacturers, who are

Teen misuse of O-T-C cough medicine remains at historic lows

Teen misuse of O-T-C cough medicine remains at historic lows

WASHINGTON — The 2019 results from the National Institute on Drug Abuse (NIDA) and University of Michigan’s annual drug abuse survey, Monitoring the Future, were released Wednesday showing that the number of teens using over-the-counter (O-T-C) cough medicine containing dextromethorphan (DXM) to get high decreased slightly, coming in at under 3%. When first reported in

CHPA names Beth Allgaier as a senior VP

CHPA names Beth Allgaier as a senior VP

WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced that Beth Allgaier has been named senior vice president, business development and industry relations. Allgaier will be responsible for the association’s membership, education, and meetings functions, in addition to serving as chief liaison to the retail community. She will be a member of the association’s senior

CHPA petitions FDA to establish a clear path for CBD in dietary supplements

CHPA petitions FDA to establish a clear path for CBD in dietary supplements

WASHINGTON — The Consumer Healthcare Products Association (CHPA) submitted on Thursday a citizen petition to the U.S. Food and Drug Administration (FDA) urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol (CBD) in dietary supplements. “Intense consumer demand and commercial interest

House committee approves consumer health savings bill

House committee approves consumer health savings bill

WASHINGTON — The House Ways and Means Committee on Thursday took an important step toward reinstating consumers’ ability to purchase over-the-counter (O-T-C) medicines with tax-preferred savings accounts, including Flexible Spending Arrangements (FSAs) and Health Savings Accounts (HSAs). The Restoring Access to Medication Act (H.R. 1922), authored by Representatives Ron Kind (D, Wis.), Grace Meng (D

Texas signs age-restriction law to curb teen cough medicine abuse

Texas signs age-restriction law to curb teen cough medicine abuse

WASHINGTON — On May 17th, Texas Governor Greg Abbott signed into law an age-18 requirement for the purchase of over-the-counter (O-T-C) medicines containing the cough suppressant dextromethorphan (DXM), an ingredient which is abused by some teenagers to get high. Texas is the 19thstate to prohibit the sale of O-T-C cough medicine to minors, joining other

CHPA holds successful 2019 Annual Executive Conference

CHPA holds successful 2019 Annual Executive Conference

WASHINGTON – The Consumer Healthcare Products Association (CHPA) concluded their 2019 Annual Executive Conference, held from March 17-19, at the Boca Raton Resort and Club, in Boca Raton, Fla. More than 300 executives from the over-the-counter (OTC) drug, dietary supplement, and consumer medical device sectors heard from an impressive lineup of speakers, including renowned presidential historian and Pulitzer Prize-winning

Survey shows teen misuse of O-T-C cough medicine remains very low

Survey shows teen misuse of O-T-C cough medicine remains very low

WASHINGTON — The 2018 results from the National Institute on Drug Abuse (NIDA) and University of Michigan’s annual drug abuse survey, Monitoring the Future, were released today showing that the percentage of teens using over-the-counter (O-T-C) cough medicine containing dextromethorphan (DXM) to get high remains at 3 %. When first reported in 2006, the number of teens abusing O-T-C cough medicines

CHPA welcomes new board members

CHPA welcomes new board members

WASHINGTON — New members of the Consumer Healthcare Products Association (CHPA) board of directors were elected at the association’s fall meeting, held November 14, in New York City. Gary Downing, chief executive officer, Clarion Brands, continues serving as CHPA’s board chairman. Newly elected CHPA board members at this meeting include: Paul Gama, vice president, North America